Bank Of New York Mellon Corp Neuronetics, Inc. Transaction History

Bank Of New York Mellon Corp

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.44 - $6.87 $212,179 - $423,741	61,680 New	61,680 $423,000
Q2 2022 Aug 15, 2022	SELL	$2.09 - $3.71 $121,163 - $215,079	-57,973 Reduced 48.3%	62,062 $199,000
Q1 2022 May 11, 2022	BUY	$2.84 - $4.52 $488 - $777	172 Added 0.14%	120,035 $363,000
Q4 2021 Feb 11, 2022	BUY	$3.87 - $6.59 $5,286 - $9,001	1,366 Added 1.15%	119,863 $534,000
Q3 2021 Nov 12, 2021	BUY	$6.22 - $15.54 $68,208 - $170,411	10,966 Added 10.2%	118,497 $777,000

Q2 2021 Aug 11, 2021	BUY	$10.15 - $17.25 $422,889 - $718,704	41,664 Added 63.25%	107,531 $1.72 Million
Q1 2021 May 13, 2021	SELL	$10.6 - $21.27 $110,314 - $221,356	-10,407 Reduced 13.64%	65,867 $814,000
Q4 2020 Feb 09, 2021	BUY	$4.95 - $11.45 $47,049 - $108,832	9,505 Added 14.24%	76,274 $847,000
Q2 2020 Aug 12, 2020	BUY	$1.41 - $2.61 $27,118 - $50,198	19,233 Added 40.46%	66,769 $128,000
Q1 2020 May 06, 2020	BUY	$1.28 - $4.5 $21,231 - $74,641	16,587 Added 53.59%	47,536 $89,000
Q4 2019 Feb 14, 2020	BUY	$4.03 - $9.22 $3,143 - $7,191	780 Added 2.59%	30,949 $138,000
Q3 2019 Nov 07, 2019	SELL	$8.31 - $13.03 $11,110 - $17,421	-1,337 Reduced 4.24%	30,169 $250,000
Q2 2019 Aug 12, 2019	BUY	$9.0 - $17.2 $11,430 - $21,844	1,270 Added 4.2%	31,506 $394,000
Q1 2019 May 14, 2019	BUY	$13.6 - $19.58 $151,776 - $218,512	11,160 Added 58.5%	30,236 $461,000
Q4 2018 Feb 11, 2019	BUY	$16.0 - $31.84 $71,328 - $141,942	4,458 Added 30.5%	19,076 $370,000
Q3 2018 Nov 09, 2018	BUY	$24.32 - $37.54 $355,509 - $548,759	14,618 New	14,618 $0

18.4M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $49.7M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.